DEXTROAMPHETAMINE SULFATE

DEXTROAMPHETAMINE SULFATE was reported 41905 times

DEXTROAMPHETAMINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ELECTROCARDIOGRAM NORMAL 5 0.1786
1 CORONARY OSTIAL STENOSIS 8 0.0635
2 POSTMORTEM BLOOD DRUG LEVEL ABNORMAL 7 0.0476
3 COELIAC ARTERY COMPRESSION SYNDROME 3 0.0400
4 AUTONOMIC DYSREFLEXIA 3 0.0185
5 HLA MARKER STUDY POSITIVE 3 0.0183
6 FIBROMUSCULAR DYSPLASIA 3 0.0183
7 GROSS MOTOR DELAY 5 0.0176
8 PH URINE INCREASED 3 0.0173
9 CATAPLEXY 22 0.0155
10 HAEMOGLOBIN URINE PRESENT 3 0.0148
11 PRE-EXISTING CONDITION IMPROVED 83 0.0133
12 MACULAR DETACHMENT 3 0.0124
13 MANUFACTURING MATERIALS ISSUE 5 0.0124
14 HYPERDYNAMIC LEFT VENTRICLE 3 0.0122
15 MIXED CONNECTIVE TISSUE DISEASE 5 0.0119
16 TOXICOLOGIC TEST ABNORMAL 7 0.0116
17 NARCOLEPSY 21 0.0111
18 IMMATURE GRANULOCYTE COUNT INCREASED 3 0.0106
19 CORONARY ARTERY DISSECTION 9 0.0105
20 PLAGIOCEPHALY 5 0.0100
21 EXECUTIVE DYSFUNCTION 5 0.0092
22 INFERTILITY MALE 4 0.0088
23 PRODUCT ADMINISTRATION INTERRUPTED 66 0.0084
24 SPINAL CORD OEDEMA 3 0.0081
25 ATTENTION DEFICIT HYPERACTIVITY DISORDER 32 0.0076
26 SLEEP-RELATED EATING DISORDER 7 0.0075
27 ABNORMAL SLEEP-RELATED EVENT 9 0.0068
28 SLEEP ATTACKS 3 0.0063
29 PSYCHIATRIC DECOMPENSATION 12 0.0061
30 SOCIAL ANXIETY DISORDER 4 0.0061
31 MENTAL FATIGUE 9 0.0060
32 SUBSTANCE USE 9 0.0058
33 ENURESIS 23 0.0057
34 PRODUCT NAME CONFUSION 6 0.0055
35 ADRENAL HAEMORRHAGE 3 0.0054
36 ENDOSCOPY 3 0.0050
37 ABDOMINAL SYMPTOM 4 0.0050
38 ORGASM ABNORMAL 4 0.0049
39 ALLERGY TO METALS 3 0.0049
40 SLEEP APNOEA SYNDROME 94 0.0049
41 PRODUCT AVAILABILITY ISSUE 102 0.0045
42 DRUG EFFECT VARIABLE 5 0.0044
43 LICHEN SCLEROSUS 3 0.0044
44 NASAL OPERATION 3 0.0044
45 PAINFUL ERECTION 3 0.0044
46 HAEMORRHAGIC CEREBRAL INFARCTION 3 0.0043
47 HYPERTENSIVE EMERGENCY 5 0.0042
48 EDUCATIONAL PROBLEM 7 0.0042
49 FACIAL ASYMMETRY 4 0.0042
50 PARASOMNIA 3 0.0042
51 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 17 0.0041
52 SLEEP PARALYSIS 6 0.0041
53 GENERALISED ANXIETY DISORDER 6 0.0041
54 OESOPHAGEAL DISCOMFORT 3 0.0040
55 CHOROIDAL EFFUSION 3 0.0037
56 DENTAL OPERATION 9 0.0036
57 SUDDEN ONSET OF SLEEP 5 0.0036
58 ESSENTIAL TREMOR 4 0.0036
59 GLOMERULAR FILTRATION RATE ABNORMAL 5 0.0035
60 SOMNAMBULISM 23 0.0035
61 IMPULSIVE BEHAVIOUR 13 0.0035
62 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
63 COCCYDYNIA 5 0.0034
64 EPICONDYLITIS 5 0.0033
65 BLADDER PROLAPSE 4 0.0033
66 SNORING 12 0.0032
67 DRUG TOLERANCE 16 0.0032
68 MOTION SICKNESS 6 0.0031
69 ANTISOCIAL BEHAVIOUR 3 0.0030
70 POST-TRAUMATIC STRESS DISORDER 20 0.0030
71 HYPOGONADISM 3 0.0030
72 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 4 0.0030
73 SUPRAVENTRICULAR EXTRASYSTOLES 10 0.0030
74 LIBIDO INCREASED 6 0.0030
75 PRODUCT COATING ISSUE 3 0.0029
76 CHRONIC FATIGUE SYNDROME 4 0.0029
77 GLUTEN SENSITIVITY 4 0.0028
78 BINGE EATING 3 0.0028
79 TIC 15 0.0027
80 SUSPECTED PRODUCT QUALITY ISSUE 5 0.0027
81 COLONOSCOPY 6 0.0027
82 DEMENTIA WITH LEWY BODIES 3 0.0027
83 YAWNING 7 0.0026
84 DISTRACTIBILITY 3 0.0026
85 HANGOVER 9 0.0026
86 SLOW SPEECH 6 0.0025
87 RENAL ATROPHY 3 0.0024
88 SHOULDER OPERATION 10 0.0023
89 BIPOLAR DISORDER 24 0.0022
90 ESSENTIAL HYPERTENSION 4 0.0022
91 CONNECTIVE TISSUE DISORDER 3 0.0021
92 BRAIN FOG 33 0.0021
93 HYPOTHALAMO-PITUITARY DISORDER 3 0.0021
94 DISTURBANCE IN ATTENTION 111 0.0021
95 CARDIAC FIBRILLATION 3 0.0020
96 COMPLEX REGIONAL PAIN SYNDROME 3 0.0020
97 CORONARY ARTERY STENOSIS 10 0.0020
98 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 4 0.0019
99 METABOLIC ALKALOSIS 3 0.0019
100 APATHY 27 0.0018
101 GASTRIC BYPASS 4 0.0018
102 DENTAL IMPLANTATION 3 0.0018
103 BREAST ENLARGEMENT 6 0.0018
104 SEBORRHOEIC DERMATITIS 3 0.0018
105 POTENTIATING DRUG INTERACTION 6 0.0018
106 PRODUCT SOLUBILITY ABNORMAL 9 0.0018
107 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 3 0.0018
108 SUSPECTED COUNTERFEIT PRODUCT 7 0.0018
109 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 4 0.0017
110 TACHYPHRENIA 6 0.0017
111 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
112 GROWTH RETARDATION 5 0.0017
113 TERMINAL INSOMNIA 3 0.0017
114 PHARMACEUTICAL PRODUCT COMPLAINT 44 0.0017
115 ENERGY INCREASED 10 0.0017
116 PUSTULE 4 0.0017
117 WEIGHT ABNORMAL 4 0.0017
118 CRANIOCEREBRAL INJURY 5 0.0017
119 THERAPEUTIC RESPONSE UNEXPECTED 74 0.0016
120 MAJOR DEPRESSION 12 0.0016
121 CARTILAGE INJURY 4 0.0016
122 BLADDER SPASM 3 0.0016
123 THERAPEUTIC RESPONSE CHANGED 10 0.0016
124 EXTRASYSTOLES 11 0.0016
125 APPENDICITIS PERFORATED 4 0.0016
126 PARANOIA 27 0.0016
127 INITIAL INSOMNIA 16 0.0016
128 THERAPEUTIC PRODUCT EFFECT VARIABLE 6 0.0015
129 NASAL SEPTUM DEVIATION 3 0.0015
130 SUSPECTED COVID-19 5 0.0015
131 ROSACEA 7 0.0015
132 ANIMAL BITE 4 0.0015
133 LYME DISEASE 5 0.0015
134 EJACULATION FAILURE 3 0.0015
135 SPINAL FUSION SURGERY 6 0.0015
136 HEPATIC CYST 5 0.0015
137 HYPERSOMNIA 42 0.0015
138 SPINAL OPERATION 18 0.0015
139 LIMB OPERATION 7 0.0015
140 SPINAL STENOSIS 6 0.0015
141 VITAMIN D DEFICIENCY 14 0.0014
142 LIP DRY 13 0.0014
143 SLEEP TERROR 6 0.0014
144 AFFECTIVE DISORDER 11 0.0014
145 BLOOD TESTOSTERONE INCREASED 3 0.0014
146 JAW FRACTURE 3 0.0014
147 PSYCHOTIC DISORDER 41 0.0014
148 PULMONARY PAIN 4 0.0014
149 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
150 HUNGER 19 0.0014
151 SEBORRHOEA 5 0.0014
152 PSYCHIATRIC SYMPTOM 10 0.0014
153 FEELING DRUNK 10 0.0013
154 MUSCLE TWITCHING 31 0.0013
155 AUTOIMMUNE THYROIDITIS 5 0.0013
156 PERIARTHRITIS 3 0.0013
157 HAEMATOCRIT INCREASED 3 0.0013
158 BRAIN OPERATION 3 0.0013
159 DISSOCIATION 10 0.0013
160 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
161 PRODUCT SUBSTITUTION ISSUE 74 0.0013
162 EUPHORIC MOOD 13 0.0013
163 DRUG EFFECT INCREASED 4 0.0013
164 PSYCHOMOTOR HYPERACTIVITY 21 0.0013
165 SINUS OPERATION 3 0.0013
166 SEROTONIN SYNDROME 24 0.0012
167 AFFECT LABILITY 12 0.0012
168 OBSESSIVE-COMPULSIVE DISORDER 10 0.0012
169 DIABETES INSIPIDUS 3 0.0012
170 SUBSTANCE ABUSE 10 0.0012
171 DERMAL CYST 3 0.0012
172 LISTLESS 4 0.0012
173 PRODUCT FORMULATION ISSUE 8 0.0012
174 PANIC ATTACK 44 0.0012
175 VEIN DISORDER 6 0.0012
176 SEXUAL DYSFUNCTION 14 0.0012
177 FIBROMYALGIA 29 0.0012
178 PLANTAR FASCIITIS 4 0.0012
179 EXCORIATION 3 0.0012
180 HOSTILITY 3 0.0012
181 INCREASED BRONCHIAL SECRETION 3 0.0012
182 DRUG TITRATION ERROR 3 0.0012
183 ACTIVITIES OF DAILY LIVING IMPAIRED 23 0.0012
184 POOR QUALITY SLEEP 25 0.0012
185 HERNIA REPAIR 3 0.0012
186 FEELING JITTERY 22 0.0012
187 HYPOPNOEA 4 0.0012
188 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0011
189 SURGERY 67 0.0011
190 DYSPHEMIA 5 0.0011
191 RADICULOPATHY 3 0.0011
192 SCOLIOSIS 7 0.0011
193 ANAL FISTULA 6 0.0011
194 PRODUCT CONTAMINATION 4 0.0011
195 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
196 ALCOHOL ABUSE 3 0.0011
197 COELIAC DISEASE 11 0.0011
198 BLEPHAROSPASM 7 0.0011
199 MIGRAINE 106 0.0011
200 PANIC REACTION 8 0.0011
201 SEDATION 29 0.0011
202 ANORGASMIA 3 0.0011
203 BACK INJURY 12 0.0011
204 MONOCYTE COUNT INCREASED 4 0.0011
205 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
206 SPONDYLITIS 4 0.0011
207 RESTLESS LEGS SYNDROME 20 0.0011
208 IRRITABILITY 66 0.0011
209 INTENTIONAL SELF-INJURY 22 0.0011
210 RED BLOOD CELL COUNT INCREASED 3 0.0011
211 DENTAL CARIES 12 0.0011
212 ELECTRIC SHOCK SENSATION 3 0.0011
213 BRADYPHRENIA 7 0.0011
214 UMBILICAL HERNIA 5 0.0011
215 OBESITY 17 0.0011
216 DISABILITY 21 0.0011
217 SEASONAL ALLERGY 15 0.0011
218 EJACULATION DISORDER 3 0.0011
219 OESOPHAGEAL STENOSIS 3 0.0011
220 COMMUNICATION DISORDER 4 0.0010
221 INCONTINENCE 11 0.0010
222 HYPERTONIC BLADDER 3 0.0010
223 COLITIS ISCHAEMIC 7 0.0010
224 SOCIAL AVOIDANT BEHAVIOUR 6 0.0010
225 MANIA 17 0.0010
226 PANIC DISORDER 4 0.0010
227 PELVIC FRACTURE 8 0.0010
228 MOOD ALTERED 28 0.0010
229 NEGATIVE THOUGHTS 3 0.0010
230 NECK INJURY 3 0.0010
231 KNEE OPERATION 10 0.0010
232 DEPRESSION 231 0.0010
233 HEPATITIS FULMINANT 3 0.0010
234 SMALL FOR DATES BABY 5 0.0010
235 BLADDER DISORDER 10 0.0010
236 INTERVERTEBRAL DISC PROTRUSION 22 0.0010
237 HEPATIC ENZYME ABNORMAL 5 0.0010
238 ANAL INCONTINENCE 9 0.0010
239 BRAIN INJURY 10 0.0010
240 BLEPHARITIS 4 0.0010
241 INTRACRANIAL ANEURYSM 4 0.0010
242 CEREBROVASCULAR DISORDER 3 0.0010
243 LOSS OF EMPLOYMENT 3 0.0010
244 VENTRICULAR FIBRILLATION 11 0.0010
245 IRITIS 3 0.0010
246 SOMNOLENCE 195 0.0010
247 STOMACH DISCOMFORT 5 0.0010
248 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
249 SUICIDAL BEHAVIOUR 4 0.0010
250 THERAPEUTIC RESPONSE DECREASED 58 0.0010
251 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
252 CORONARY ARTERY OCCLUSION 13 0.0009
253 ANXIETY 269 0.0009
254 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
255 FOOD POISONING 5 0.0009
256 ROAD TRAFFIC ACCIDENT 39 0.0009
257 ANAL FISSURE 5 0.0009
258 BRUXISM 5 0.0009
259 HYSTERECTOMY 8 0.0009
260 PRODUCT DISPENSING ERROR 20 0.0009
261 MENTAL IMPAIRMENT 22 0.0009
262 HYPERKERATOSIS 5 0.0009
263 NOCTURIA 11 0.0009
264 SKIN INJURY 3 0.0009
265 ANKLE FRACTURE 14 0.0009
266 CONGENITAL ANOMALY 7 0.0009
267 ANXIETY DISORDER 3 0.0009
268 FOOT FRACTURE 17 0.0009
269 SUICIDAL IDEATION 82 0.0009
270 WRONG PRODUCT ADMINISTERED 6 0.0009
271 URINE ABNORMALITY 4 0.0009
272 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
273 IMMUNE THROMBOCYTOPENIA 4 0.0009
274 UNEVALUABLE EVENT 66 0.0009
275 RESPIRATION ABNORMAL 6 0.0009
276 SENSORY LOSS 7 0.0009
277 ARTHRITIS 68 0.0009
278 SKIN WARM 5 0.0009
279 ANGER 29 0.0009
280 COGNITIVE DISORDER 40 0.0009
281 LOGORRHOEA 3 0.0009
282 DEPRESSED MOOD 45 0.0009
283 DEPRESSIVE SYMPTOM 3 0.0009
284 FEELING ABNORMAL 203 0.0008
285 SINUS HEADACHE 5 0.0008
286 AGGRESSION 42 0.0008
287 ENDOMETRIOSIS 4 0.0008
288 TYPE 1 DIABETES MELLITUS 5 0.0008
289 PRESCRIBED OVERDOSE 16 0.0008
290 INGUINAL HERNIA 5 0.0008
291 INTENTIONAL PRODUCT USE ISSUE 72 0.0008
292 HYPOMANIA 3 0.0008
293 PARADOXICAL DRUG REACTION 3 0.0008
294 CEREBRAL DISORDER 6 0.0008
295 DRUG DIVERSION 5 0.0008
296 FOOT OPERATION 4 0.0008
297 INTENTIONAL DOSE OMISSION 23 0.0008
298 MIDDLE INSOMNIA 15 0.0008
299 PROTEIN URINE PRESENT 4 0.0008
300 CHRONIC SINUSITIS 3 0.0008
301 NASAL DRYNESS 5 0.0008
302 FACE INJURY 3 0.0008
303 CARPAL TUNNEL SYNDROME 11 0.0008
304 CLAVICLE FRACTURE 3 0.0008
305 ABNORMAL BEHAVIOUR 31 0.0008
306 FOOD ALLERGY 6 0.0008
307 REHABILITATION THERAPY 3 0.0008
308 TRISMUS 4 0.0008
309 DELUSION 12 0.0008
310 IMPAIRED QUALITY OF LIFE 11 0.0008
311 SKIN ODOUR ABNORMAL 3 0.0008
312 DRUG SCREEN POSITIVE 6 0.0008
313 ANKYLOSING SPONDYLITIS 10 0.0008
314 MENTAL DISORDER 33 0.0008
315 MYOCLONUS 9 0.0008
316 NYSTAGMUS 4 0.0008
317 PERSONALITY CHANGE 7 0.0008
318 MOOD SWINGS 24 0.0008
319 LEARNING DISABILITY 4 0.0008
320 OBSTRUCTION 3 0.0008
321 INSOMNIA 200 0.0008
322 IMPAIRED WORK ABILITY 16 0.0007
323 HEREDITARY ANGIOEDEMA 8 0.0007
324 HOMICIDAL IDEATION 3 0.0007
325 BEHAVIOUR DISORDER 4 0.0007
326 PRODUCT TASTE ABNORMAL 10 0.0007
327 HYDROCEPHALUS 4 0.0007
328 OSTEOPENIA 11 0.0007
329 SOCIAL PROBLEM 3 0.0007
330 DRUG EFFECT DECREASED 39 0.0007
331 THERAPEUTIC RESPONSE SHORTENED 24 0.0007
332 INSURANCE ISSUE 11 0.0007
333 AUTOIMMUNE DISORDER 7 0.0007
334 INTENTIONAL OVERDOSE 46 0.0007
335 INFLAMMATORY BOWEL DISEASE 7 0.0007
336 CRYING 26 0.0007
337 DRY MOUTH 58 0.0007
338 LETHARGY 41 0.0007
339 THERAPY PARTIAL RESPONDER 11 0.0007
340 AORTIC VALVE INCOMPETENCE 3 0.0007
341 BLOOD PRESSURE ABNORMAL 14 0.0007
342 VITAMIN D DECREASED 6 0.0007
343 MYDRIASIS 9 0.0007
344 BRONCHOSPASM 10 0.0007
345 PRODUCT SUPPLY ISSUE 5 0.0007
346 SLEEP DISORDER 49 0.0007
347 PRODUCT PHYSICAL ISSUE 14 0.0007
348 HALLUCINATION, AUDITORY 11 0.0007
349 HYPERVENTILATION 4 0.0007
350 METABOLIC DISORDER 4 0.0007
351 SLUGGISHNESS 7 0.0007
352 ONYCHOMYCOSIS 3 0.0007
353 URINE ODOUR ABNORMAL 4 0.0007
354 HYPERCHLORHYDRIA 4 0.0007
355 BACK DISORDER 11 0.0007
356 NEPHROLITHIASIS 31 0.0007
357 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
358 HYPERLIPIDAEMIA 8 0.0007
359 MUSCLE RIGIDITY 8 0.0007
360 AGITATION 49 0.0007
361 HEART RATE INCREASED 66 0.0007
362 HEAD INJURY 21 0.0007
363 IMPAIRED GASTRIC EMPTYING 9 0.0007
364 HYPOTHYROIDISM 21 0.0007
365 TENSION 4 0.0007
366 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
367 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
368 CONCUSSION 5 0.0006
369 TOOTH EXTRACTION 8 0.0006
370 URINARY INCONTINENCE 19 0.0006
371 MULTIPLE ALLERGIES 5 0.0006
372 BLOOD PROLACTIN INCREASED 3 0.0006
373 SPINAL COLUMN STENOSIS 3 0.0006
374 GASTROOESOPHAGEAL REFLUX DISEASE 51 0.0006
375 RENAL CYST 5 0.0006
376 SCREAMING 4 0.0006
377 GUILLAIN-BARRE SYNDROME 3 0.0006
378 FRUSTRATION TOLERANCE DECREASED 5 0.0006
379 CARDIAC FLUTTER 4 0.0006
380 INCOHERENT 4 0.0006
381 NEURALGIA 15 0.0006
382 HORMONE LEVEL ABNORMAL 3 0.0006
383 BEDRIDDEN 8 0.0006
384 EXTRAPYRAMIDAL DISORDER 15 0.0006
385 EAR INFECTION 16 0.0006
386 RESTLESSNESS 22 0.0006
387 MENINGITIS 4 0.0006
388 WITHDRAWAL SYNDROME 25 0.0006
389 PRODUCT LABEL ISSUE 4 0.0006
390 TOOTH ABSCESS 6 0.0006
391 TREATMENT NONCOMPLIANCE 32 0.0006
392 BLOOD TESTOSTERONE DECREASED 4 0.0006
393 RIB FRACTURE 12 0.0006
394 BLOOD PRESSURE INCREASED 89 0.0006
395 TEMPERATURE INTOLERANCE 6 0.0006
396 ONYCHOCLASIS 4 0.0006
397 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
398 WEIGHT DECREASED 161 0.0006
399 TENDERNESS 6 0.0006
400 PALPITATIONS 67 0.0006
401 SPINAL OSTEOARTHRITIS 5 0.0006
402 HERNIA 11 0.0006
403 HYPERHIDROSIS 73 0.0006
404 SHOCK 13 0.0006
405 RETCHING 12 0.0006
406 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
407 SENSORY DISTURBANCE 9 0.0006
408 CARDIOGENIC SHOCK 8 0.0006
409 ANAL ABSCESS 3 0.0006
410 STRESS FRACTURE 3 0.0006
411 GASTROENTERITIS VIRAL 10 0.0006
412 HYPERTHYROIDISM 8 0.0006
413 SKIN LACERATION 6 0.0006
414 NIGHTMARE 19 0.0005
415 EXOSTOSIS 5 0.0005
416 ERECTILE DYSFUNCTION 14 0.0005
417 ROTATOR CUFF SYNDROME 7 0.0005
418 INFUSION SITE PAIN 7 0.0005
419 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
420 DRY EYE 27 0.0005
421 HIATUS HERNIA 7 0.0005
422 TOOTH DISORDER 12 0.0005
423 NERVE INJURY 6 0.0005
424 HEART RATE ABNORMAL 3 0.0005
425 THINKING ABNORMAL 10 0.0005
426 SUNBURN 4 0.0005
427 ACUTE PULMONARY OEDEMA 3 0.0005
428 BLOOD SODIUM DECREASED 10 0.0005
429 HYPERTENSION 112 0.0005
430 SPINAL DISORDER 5 0.0005
431 ECONOMIC PROBLEM 8 0.0005
432 INCREASED APPETITE 10 0.0005
433 TINNITUS 24 0.0005
434 APHTHOUS ULCER 4 0.0005
435 VASCULITIS 6 0.0005
436 BLOOD CHOLESTEROL INCREASED 24 0.0005
437 PHARYNGEAL SWELLING 5 0.0005
438 LYMPHOCYTE COUNT DECREASED 9 0.0005
439 BODY TEMPERATURE DECREASED 5 0.0005
440 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
441 AMNESIA 33 0.0005
442 PRODUCT DOSE OMISSION ISSUE 149 0.0005
443 CATARACT OPERATION 3 0.0005
444 DRUG INEFFECTIVE 664 0.0005
445 INABILITY TO AFFORD MEDICATION 5 0.0005
446 ACCIDENT 6 0.0005
447 COORDINATION ABNORMAL 7 0.0005
448 SINUSITIS 51 0.0005
449 PLATELET COUNT ABNORMAL 3 0.0005
450 TACHYCARDIA 44 0.0005
451 HYPOTHERMIA 5 0.0005
452 POST PROCEDURAL INFECTION 4 0.0005
453 PARALYSIS 7 0.0005
454 NEUTROPHIL COUNT INCREASED 5 0.0005
455 MENISCUS INJURY 3 0.0005
456 PRODUCT PREPARATION ERROR 10 0.0005
457 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
458 GYNAECOMASTIA 15 0.0005
459 PHARYNGITIS 6 0.0005
460 ANOSMIA 7 0.0005
461 POLLAKIURIA 20 0.0005
462 DYSPNOEA EXERTIONAL 18 0.0005
463 ACUTE MYOCARDIAL INFARCTION 14 0.0005
464 SENSATION OF FOREIGN BODY 4 0.0005
465 CANDIDA INFECTION 8 0.0005
466 WEIGHT INCREASED 106 0.0005
467 JOINT DISLOCATION 5 0.0005
468 TREMOR 78 0.0005
469 JOINT INJURY 10 0.0005
470 MOVEMENT DISORDER 15 0.0005
471 BLOOD MAGNESIUM DECREASED 4 0.0005
472 DECREASED ACTIVITY 5 0.0005
473 DIPLOPIA 12 0.0005
474 HAEMORRHOIDS 9 0.0005
475 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
476 POLYP 3 0.0005
477 DRUG ADMINISTRATION ERROR 14 0.0005
478 HEART RATE DECREASED 16 0.0005
479 TOOTH INFECTION 6 0.0005
480 DISORIENTATION 18 0.0005
481 EMOTIONAL DISORDER 14 0.0005
482 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
483 HEAD DISCOMFORT 8 0.0005
484 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
485 FOOT DEFORMITY 5 0.0005
486 RESPIRATORY RATE INCREASED 4 0.0005
487 WRONG DRUG ADMINISTERED 4 0.0004
488 THERAPEUTIC PRODUCT EFFECT DECREASED 20 0.0004
489 HEAVY MENSTRUAL BLEEDING 4 0.0004
490 MEMORY IMPAIRMENT 61 0.0004
491 NERVOUSNESS 23 0.0004
492 IMPAIRED DRIVING ABILITY 5 0.0004
493 GINGIVAL BLEEDING 6 0.0004
494 DERMATITIS CONTACT 5 0.0004
495 MICTURITION URGENCY 5 0.0004
496 NIGHT SWEATS 14 0.0004
497 LYMPHOEDEMA 3 0.0004
498 IRON DEFICIENCY ANAEMIA 4 0.0004
499 FORMICATION 3 0.0004
500 APHONIA 6 0.0004
501 HEPATIC STEATOSIS 8 0.0004
502 SUICIDE ATTEMPT 26 0.0004
503 CHOLELITHIASIS 14 0.0004
504 HAND FRACTURE 3 0.0004
505 DIVERTICULUM 3 0.0004
506 LIMB DISCOMFORT 13 0.0004
507 DIABETES MELLITUS 32 0.0004
508 GASTRITIS 11 0.0004
509 CONDITION AGGRAVATED 127 0.0004
510 POST PROCEDURAL COMPLICATION 8 0.0004
511 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
512 PARAESTHESIA ORAL 6 0.0004
513 HYPERCHOLESTEROLAEMIA 4 0.0004
514 FLUID RETENTION 21 0.0004
515 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
516 RASH PUSTULAR 3 0.0004
517 PARKINSONISM 4 0.0004
518 ORAL HERPES 8 0.0004
519 ORAL DISORDER 3 0.0004
520 THERAPY CHANGE 4 0.0004
521 MUSCULOSKELETAL DISCOMFORT 7 0.0004
522 CARDIOMEGALY 5 0.0004
523 BLOOD PRESSURE DECREASED 27 0.0004
524 CARDIOMYOPATHY 6 0.0004
525 BRONCHITIS 30 0.0004
526 LIMB INJURY 11 0.0004
527 PRODUCT QUALITY ISSUE 55 0.0004
528 LIGAMENT SPRAIN 4 0.0004
529 SINUS DISORDER 8 0.0004
530 HAEMATOCRIT DECREASED 8 0.0004
531 ORTHOSTATIC HYPOTENSION 7 0.0004
532 GASTROINTESTINAL DISORDER 36 0.0004
533 HYPOAESTHESIA 60 0.0004
534 SPINAL FRACTURE 8 0.0004
535 APHASIA 12 0.0004
536 COLD SWEAT 7 0.0004
537 MEDICATION ERROR 22 0.0004
538 DISCOMFORT 24 0.0004
539 DRUG DISPENSING ERROR 6 0.0004
540 THIRST 7 0.0004
541 FATIGUE 305 0.0004
542 ADVERSE EVENT 36 0.0004
543 RENAL FAILURE CHRONIC 3 0.0004
544 GOUT 7 0.0004
545 TENDONITIS 6 0.0004
546 MUSCLE SPASMS 71 0.0004
547 VENTRICULAR EXTRASYSTOLES 4 0.0004
548 SWOLLEN TONGUE 12 0.0004
549 HAEMORRHAGIC STROKE 3 0.0004
550 PETECHIAE 4 0.0004
551 FOLLICULITIS 4 0.0004
552 JOINT STIFFNESS 10 0.0004
553 HEADACHE 238 0.0004
554 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
555 FURUNCLE 3 0.0004
556 NASAL DISCOMFORT 3 0.0004
557 PRODUCT PRESCRIBING ERROR 9 0.0004
558 SCIATICA 6 0.0004
559 ATRIAL FLUTTER 3 0.0004
560 EATING DISORDER 8 0.0004
561 BLOOD DISORDER 3 0.0004
562 BODY HEIGHT DECREASED 4 0.0004
563 IRRITABLE BOWEL SYNDROME 8 0.0004
564 QUALITY OF LIFE DECREASED 5 0.0004
565 LOCALISED INFECTION 9 0.0004
566 RHINITIS 3 0.0004
567 FEAR 10 0.0004
568 MUSCLE DISORDER 3 0.0004
569 MUSCLE TIGHTNESS 6 0.0004
570 BALANCE DISORDER 32 0.0004
571 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 75 0.0004
572 DYSKINESIA 15 0.0004
573 ILLNESS 38 0.0004
574 WOUND INFECTION 4 0.0004
575 ASPIRATION 4 0.0004
576 SKIN LESION 10 0.0004
577 VISION BLURRED 50 0.0004
578 GASTROINTESTINAL PAIN 4 0.0004
579 TOOTH FRACTURE 4 0.0004
580 ABNORMAL DREAMS 10 0.0004
581 DYSTONIA 7 0.0004
582 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
583 NECK PAIN 20 0.0004
584 SEIZURE 41 0.0004
585 CHROMATURIA 8 0.0004
586 INADEQUATE ANALGESIA 3 0.0004
587 CIRCULATORY COLLAPSE 6 0.0004
588 SINUS TACHYCARDIA 5 0.0004
589 CHOLECYSTECTOMY 4 0.0003
590 CONVULSION 20 0.0003
591 CARDIAC MURMUR 3 0.0003
592 VERTIGO 21 0.0003
593 HYPOKINESIA 5 0.0003
594 SPEECH DISORDER 18 0.0003
595 PARAESTHESIA 54 0.0003
596 SPINAL PAIN 4 0.0003
597 OSTEOPOROSIS 14 0.0003
598 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
599 FACIAL PAIN 3 0.0003
600 CARDIO-RESPIRATORY ARREST 14 0.0003
601 NAUSEA 264 0.0003
602 BLOOD POTASSIUM DECREASED 10 0.0003
603 HALLUCINATION, VISUAL 7 0.0003
604 TOOTHACHE 6 0.0003
605 LUPUS-LIKE SYNDROME 3 0.0003
606 OSTEOARTHRITIS 14 0.0003
607 ILL-DEFINED DISORDER 20 0.0003
608 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
609 NASOPHARYNGITIS 60 0.0003
610 DYSPEPSIA 32 0.0003
611 PHARYNGEAL OEDEMA 5 0.0003
612 THYROID DISORDER 5 0.0003
613 OROPHARYNGEAL PAIN 30 0.0003
614 CHEST PAIN 60 0.0003
615 CYST 4 0.0003
616 ABDOMINAL DISCOMFORT 54 0.0003
617 CONFUSIONAL STATE 52 0.0003
618 APPENDICITIS 3 0.0003
619 BRADYCARDIA 17 0.0003
620 LACERATION 3 0.0003
621 CYSTITIS 10 0.0003
622 MULTIPLE SCLEROSIS 15 0.0003
623 ABSCESS 5 0.0003
624 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
625 DRUG PRESCRIBING ERROR 6 0.0003
626 ATELECTASIS 3 0.0003
627 INFLAMMATION 16 0.0003
628 FALL 103 0.0003
629 EAR PAIN 6 0.0003
630 INTENTIONAL PRODUCT MISUSE 27 0.0003
631 TOXICITY TO VARIOUS AGENTS 52 0.0003
632 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
633 CHOKING 6 0.0003
634 RESPIRATORY TRACT INFECTION 8 0.0003
635 DECREASED APPETITE 71 0.0003
636 HOSPICE CARE 3 0.0003
637 IMMUNE SYSTEM DISORDER 4 0.0003
638 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
639 CONTUSION 29 0.0003
640 DIZZINESS 150 0.0003
641 HYPOTONIA 3 0.0003
642 VIRAL INFECTION 10 0.0003
643 SALIVARY HYPERSECRETION 3 0.0003
644 BLOOD UREA INCREASED 5 0.0003
645 EYE PRURITUS 10 0.0003
646 EYELID PTOSIS 3 0.0003
647 DRUG INTERACTION 46 0.0003
648 POOR VENOUS ACCESS 3 0.0003
649 PULMONARY HYPERTENSION 6 0.0003
650 INFLUENZA 32 0.0003
651 MASS 4 0.0003
652 ENCEPHALOPATHY 7 0.0003
653 DRUG WITHDRAWAL SYNDROME 25 0.0003
654 NEUROPATHY PERIPHERAL 27 0.0003
655 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
656 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
657 AGEUSIA 7 0.0003
658 HYPERSENSITIVITY 52 0.0003
659 GALLBLADDER DISORDER 5 0.0003
660 DRUG INTOLERANCE 27 0.0003
661 HEPATIC ENZYME INCREASED 19 0.0003
662 ATRIAL FIBRILLATION 27 0.0003
663 ASTHENIA 103 0.0003
664 EXPOSURE DURING PREGNANCY 17 0.0003
665 STAPHYLOCOCCAL INFECTION 9 0.0003
666 NASAL CONGESTION 16 0.0003
667 SKIN HAEMORRHAGE 4 0.0003
668 SKIN DISORDER 9 0.0003
669 CATARACT 16 0.0003
670 IMMUNODEFICIENCY 4 0.0003
671 SKIN INFECTION 3 0.0003
672 TYPE 2 DIABETES MELLITUS 9 0.0003
673 OCULAR DISCOMFORT 3 0.0003
674 ANHEDONIA 7 0.0003
675 HEART RATE IRREGULAR 6 0.0003
676 HALLUCINATION 20 0.0003
677 HYPOAESTHESIA ORAL 4 0.0003
678 MITRAL VALVE INCOMPETENCE 3 0.0003
679 DRUG ABUSE 22 0.0003
680 OVERDOSE 57 0.0003
681 PROTEINURIA 5 0.0003
682 MULTIPLE SCLEROSIS RELAPSE 18 0.0003
683 MUSCULOSKELETAL STIFFNESS 23 0.0003
684 PRODUCT USE ISSUE 49 0.0003
685 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
686 LOWER LIMB FRACTURE 5 0.0003
687 BLOOD BILIRUBIN INCREASED 7 0.0003
688 PAIN 159 0.0003
689 VISUAL IMPAIRMENT 32 0.0003
690 ELECTROLYTE IMBALANCE 3 0.0003
691 EYELID OEDEMA 3 0.0003
692 LOSS OF CONSCIOUSNESS 33 0.0003
693 COVID-19 45 0.0003
694 NERVOUS SYSTEM DISORDER 8 0.0003
695 INJURY 18 0.0003
696 RECTAL HAEMORRHAGE 11 0.0003
697 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
698 PRODUCT USE COMPLAINT 4 0.0003
699 HOSPITALISATION 39 0.0003
700 ARRHYTHMIA 12 0.0003
701 PERIPHERAL SWELLING 39 0.0003
702 DIVERTICULITIS 7 0.0003
703 ABDOMINAL PAIN UPPER 52 0.0003
704 URINARY TRACT INFECTION 43 0.0003
705 FEELING COLD 7 0.0003
706 UPPER LIMB FRACTURE 5 0.0003
707 BLOOD PRESSURE FLUCTUATION 6 0.0002
708 BACK PAIN 58 0.0002
709 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
710 MUSCULOSKELETAL PAIN 13 0.0002
711 ASTHMA 28 0.0002
712 RHINORRHOEA 16 0.0002
713 PRODUCT ADMINISTRATION ERROR 5 0.0002
714 ADRENAL INSUFFICIENCY 3 0.0002
715 SCHIZOPHRENIA 3 0.0002
716 PRESYNCOPE 6 0.0002
717 MUSCULAR WEAKNESS 28 0.0002
718 BODY TEMPERATURE INCREASED 5 0.0002
719 RESPIRATORY DEPRESSION 3 0.0002
720 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
721 MUSCLE SPASTICITY 3 0.0002
722 SMALL INTESTINAL OBSTRUCTION 3 0.0002
723 EYE DISORDER 8 0.0002
724 ABNORMAL WEIGHT GAIN 3 0.0002
725 PNEUMONIA ASPIRATION 6 0.0002
726 DEHYDRATION 32 0.0002
727 RHABDOMYOLYSIS 10 0.0002
728 DYSARTHRIA 9 0.0002
729 CHILLS 28 0.0002
730 INTESTINAL OBSTRUCTION 9 0.0002
731 PERICARDITIS 4 0.0002
732 BRAIN OEDEMA 3 0.0002
733 KNEE ARTHROPLASTY 5 0.0002
734 DRUG DEPENDENCE 38 0.0002
735 WHEEZING 14 0.0002
736 MALAISE 103 0.0002
737 ARTHROPATHY 13 0.0002
738 ADVERSE DRUG REACTION 21 0.0002
739 SCAR 4 0.0002
740 DISEASE RECURRENCE 11 0.0002
741 VOMITING 108 0.0002
742 DEAFNESS 6 0.0002
743 TREATMENT FAILURE 19 0.0002
744 DYSGEUSIA 17 0.0002
745 FEELING HOT 14 0.0002
746 COMPLETED SUICIDE 19 0.0002
747 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
748 HOT FLUSH 17 0.0002
749 LIVER DISORDER 10 0.0002
750 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
751 MALIGNANT MELANOMA 3 0.0002
752 JAUNDICE 6 0.0002
753 PANCREATITIS ACUTE 5 0.0002
754 THROAT TIGHTNESS 6 0.0002
755 LEUKOCYTOSIS 4 0.0002
756 OSTEOMYELITIS 4 0.0002
757 CONSTIPATION 48 0.0002
758 LEUKOPENIA 11 0.0002
759 GAIT DISTURBANCE 42 0.0002
760 ALOPECIA 43 0.0002
761 PERIPHERAL COLDNESS 3 0.0002
762 ANAPHYLACTIC REACTION 12 0.0002
763 DEMENTIA 6 0.0002
764 BLINDNESS UNILATERAL 3 0.0002
765 PAIN IN JAW 6 0.0002
766 COLITIS 8 0.0002
767 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
768 BLOOD URINE PRESENT 4 0.0002
769 GASTRIC ULCER 4 0.0002
770 ECZEMA 11 0.0002
771 PNEUMONIA 68 0.0002
772 FUNGAL INFECTION 7 0.0002
773 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
774 GLAUCOMA 4 0.0002
775 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
776 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
777 FLUSHING 21 0.0002
778 INFLUENZA LIKE ILLNESS 17 0.0002
779 CHEST DISCOMFORT 21 0.0002
780 KIDNEY INFECTION 4 0.0002
781 ANGIOEDEMA 9 0.0002
782 PULMONARY MASS 3 0.0002
783 RESPIRATORY DISORDER 6 0.0002
784 PULMONARY EMBOLISM 19 0.0002
785 ABORTION SPONTANEOUS 8 0.0002
786 LYMPHADENOPATHY 7 0.0002
787 FEEDING DISORDER 4 0.0002
788 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
789 HIP ARTHROPLASTY 3 0.0002
790 MUSCULOSKELETAL CHEST PAIN 3 0.0002
791 UNRESPONSIVE TO STIMULI 5 0.0002
792 RENAL DISORDER 9 0.0002
793 EJECTION FRACTION DECREASED 3 0.0002
794 DRUG EFFECT INCOMPLETE 7 0.0002
795 DYSPNOEA 109 0.0002
796 ABDOMINAL DISTENSION 20 0.0002
797 ACCIDENTAL OVERDOSE 7 0.0002
798 DYSURIA 7 0.0002
799 EMOTIONAL DISTRESS 23 0.0002
800 PANCREATITIS 10 0.0002
801 PREMATURE DELIVERY 3 0.0002
802 INFECTION 27 0.0002
803 PRURITUS GENERALISED 4 0.0002
804 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
805 PALLOR 5 0.0002
806 PRODUCT PRESCRIBING ISSUE 4 0.0002
807 OSTEONECROSIS 6 0.0002
808 MYALGIA 31 0.0002
809 DRUG LEVEL INCREASED 3 0.0002
810 HAEMATOCHEZIA 10 0.0002
811 RESPIRATORY DISTRESS 5 0.0002
812 EXPIRED PRODUCT ADMINISTERED 6 0.0002
813 COAGULOPATHY 3 0.0002
814 DIARRHOEA 116 0.0002
815 COLITIS ULCERATIVE 8 0.0002
816 OXYGEN SATURATION DECREASED 10 0.0002
817 FACE OEDEMA 3 0.0002
818 EYE PAIN 10 0.0002
819 OFF LABEL USE 155 0.0002
820 FLATULENCE 10 0.0002
821 ABDOMINAL PAIN 41 0.0002
822 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
823 THROMBOSIS 14 0.0002
824 EPISTAXIS 13 0.0002
825 EXTRA DOSE ADMINISTERED 7 0.0002
826 DRY SKIN 23 0.0002
827 ACNE 13 0.0002
828 EOSINOPHILIA 3 0.0002
829 COUGH 48 0.0002
830 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
831 DERMATITIS ATOPIC 9 0.0002
832 RASH 74 0.0002
833 BLOOD GLUCOSE DECREASED 8 0.0002
834 LACRIMATION INCREASED 5 0.0002
835 CORONARY ARTERY DISEASE 5 0.0002
836 HYPOGLYCAEMIA 8 0.0002
837 PAIN IN EXTREMITY 48 0.0002
838 ABASIA 4 0.0002
839 PRURITUS 62 0.0002
840 URTICARIA 27 0.0002
841 BACTERIAL INFECTION 3 0.0002
842 SYNCOPE 16 0.0002
843 PRODUCT COMPLAINT 4 0.0002
844 MUSCULOSKELETAL DISORDER 3 0.0002
845 CARDIOVASCULAR DISORDER 4 0.0002
846 JOINT SWELLING 19 0.0002
847 HYPOPHAGIA 4 0.0002
848 ACUTE RESPIRATORY FAILURE 3 0.0002
849 DRUG RESISTANCE 4 0.0002
850 HIP FRACTURE 5 0.0002
851 NO ADVERSE EVENT 28 0.0002
852 PRODUCT DOSE OMISSION 10 0.0002
853 MENORRHAGIA 3 0.0002
854 SKIN DISCOLOURATION 7 0.0002
855 ARTHRALGIA 63 0.0002
856 VISUAL ACUITY REDUCED 5 0.0002
857 PRESCRIBED UNDERDOSE 3 0.0002
858 URINARY RETENTION 5 0.0001
859 FREQUENT BOWEL MOVEMENTS 4 0.0001
860 TASTE DISORDER 3 0.0001
861 PSORIATIC ARTHROPATHY 6 0.0001
862 OEDEMA 8 0.0001
863 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
864 PRODUCTIVE COUGH 7 0.0001
865 HAEMOGLOBIN DECREASED 15 0.0001
866 HAEMATURIA 5 0.0001
867 GASTRIC DISORDER 5 0.0001
868 DRUG DOSE OMISSION 24 0.0001
869 PYREXIA 50 0.0001
870 DELIRIUM 5 0.0001
871 MENTAL STATUS CHANGES 4 0.0001
872 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
873 MOUTH ULCERATION 3 0.0001
874 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
875 RED BLOOD CELL COUNT DECREASED 4 0.0001
876 LIVER FUNCTION TEST INCREASED 3 0.0001
877 HYPOTENSION 28 0.0001
878 CELLULITIS 7 0.0001
879 SWELLING 13 0.0001
880 DEEP VEIN THROMBOSIS 9 0.0001
881 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
882 BLOOD CREATININE INCREASED 9 0.0001
883 C-REACTIVE PROTEIN INCREASED 5 0.0001
884 DYSSTASIA 4 0.0001
885 CARDIAC FAILURE CONGESTIVE 11 0.0001
886 DYSPHONIA 8 0.0001
887 INCORRECT DOSE ADMINISTERED 31 0.0001
888 STEVENS-JOHNSON SYNDROME 3 0.0001
889 GLOSSODYNIA 3 0.0001
890 RASH PAPULAR 3 0.0001
891 SNEEZING 3 0.0001
892 CARDIAC ARREST 11 0.0001
893 HEPATIC FAILURE 4 0.0001
894 SKIN IRRITATION 6 0.0001
895 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0001
896 BURNING SENSATION 9 0.0001
897 OCULAR HYPERAEMIA 6 0.0001
898 THERAPY INTERRUPTED 9 0.0001
899 METABOLIC ACIDOSIS 4 0.0001
900 DIABETIC KETOACIDOSIS 3 0.0001
901 BLISTER 7 0.0001
902 OEDEMA PERIPHERAL 15 0.0001
903 SWELLING FACE 8 0.0001
904 EYE IRRITATION 7 0.0001
905 OSTEONECROSIS OF JAW 3 0.0001
906 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
907 LIP SWELLING 4 0.0001
908 NEOPLASM MALIGNANT 8 0.0001
909 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
910 ABDOMINAL PAIN LOWER 3 0.0001
911 SKIN EXFOLIATION 10 0.0001
912 CHRONIC KIDNEY DISEASE 9 0.0001
913 BREAST CANCER 11 0.0001
914 ANAPHYLACTIC SHOCK 3 0.0001
915 INJECTION SITE REACTION 8 0.0001
916 HYPOACUSIS 5 0.0001
917 SKIN ULCER 3 0.0001
918 DYSPHAGIA 11 0.0001
919 RASH GENERALISED 3 0.0001
920 RASH MACULAR 4 0.0001
921 CEREBROVASCULAR ACCIDENT 19 0.0001
922 MENSTRUATION IRREGULAR 3 0.0001
923 THROAT IRRITATION 5 0.0001
924 THERAPY NON-RESPONDER 5 0.0001
925 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
926 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
927 HYPERGLYCAEMIA 4 0.0001
928 TARDIVE DYSKINESIA 3 0.0001
929 FEBRILE NEUTROPENIA 7 0.0001
930 COMA 5 0.0001
931 RASH ERYTHEMATOUS 5 0.0001
932 HERPES ZOSTER 6 0.0001
933 LIVER FUNCTION TEST ABNORMAL 3 0.0001
934 ASCITES 3 0.0001
935 RENAL INJURY 3 0.0001
936 PLEURAL EFFUSION 6 0.0001
937 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
938 MOBILITY DECREASED 7 0.0001
939 RHEUMATOID ARTHRITIS 11 0.0001
940 BONE DENSITY DECREASED 3 0.0001
941 DRUG-INDUCED LIVER INJURY 3 0.0001
942 RENAL IMPAIRMENT 8 0.0001
943 PLATELET COUNT DECREASED 10 0.0001
944 RASH PRURITIC 5 0.0001
945 SEPTIC SHOCK 4 0.0001
946 PSORIASIS 12 0.0001
947 MYOCARDIAL INFARCTION 16 0.0001
948 PRODUCT STORAGE ERROR 8 0.0001
949 HYPOKALAEMIA 4 0.0001
950 HAEMORRHAGE 9 0.0001
951 CARDIAC DISORDER 8 0.0001
952 BONE PAIN 5 0.0001
953 HYPOXIA 3 0.0001
954 CEREBRAL HAEMORRHAGE 3 0.0001
955 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
956 INTERSTITIAL LUNG DISEASE 4 0.0001
957 EYE SWELLING 3 0.0001
958 ANAEMIA 15 0.0001
959 THERAPY CESSATION 4 0.0001
960 PLASMA CELL MYELOMA 3 0.0001
961 INFUSION RELATED REACTION 5 0.0001
962 RENAL FAILURE 10 0.0001
963 PROSTATE CANCER 6 0.0001
964 DEVICE BREAKAGE 3 0.0001
965 LUNG NEOPLASM MALIGNANT 3 0.0001
966 ERYTHEMA 15 0.0001
967 HYPONATRAEMIA 4 0.0001
968 RENAL FAILURE ACUTE 3 0.0001
969 LUNG DISORDER 3 0.0001
970 INJECTION SITE PRURITUS 4 0.0001
971 BLOOD GLUCOSE INCREASED 11 0.0001
972 INJECTION SITE ERYTHEMA 7 0.0001
973 DEPENDENCE 3 0.0001
974 PANCYTOPENIA 3 0.0001
975 ACUTE KIDNEY INJURY 8 0.0001
976 STOMATITIS 3 0.0000
977 INJECTION SITE PAIN 15 0.0000
978 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
979 THROMBOCYTOPENIA 5 0.0000
980 DEVICE ISSUE 4 0.0000
981 INJECTION SITE SWELLING 3 0.0000
982 INJECTION SITE BRUISING 3 0.0000
983 SEPSIS 4 0.0000
984 DEATH 29 0.0000
985 DISEASE PROGRESSION 3 0.0000